RxDoctor Payments Data

Chelsea Drissell, MD

Family Medicine · Saint Louis, MONPI 1720573769

Payments from drug & device makers

$662in general payments, 2019–2025

Across 34 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$215
  • Baxter Healthcare$85
  • Novo Nordisk$73
  • Lilly USA, LLC$71
  • Merck$69
  • Pfizer$64
  • plus $85 from 4 others

What the payments were for

  • Food & beverage$57787%
  • Other$8513%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$662 in reported general payments places this provider in the 55th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$56,444
Medicare patients
194
Services billed
571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide29$51,207
EliquisApixaban46$47,779
TrulicityDulaglutide24$42,511
JardianceEmpagliflozin31$35,054
FarxigaDapagliflozin Propanediol13$20,902
MyrbetriqMirabegron16$15,792
MounjaroTirzepatide14$14,594
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$9,346
ArexvyRsvpref3 Antigen/As01e/Pf31$7,646
SynthroidLevothyroxine Sodium42$4,040
Atorvastatin Calcium548$3,392
Aripiprazole14$2,739
Levothyroxine Sodium384$2,699
Bupropion XlBupropion Hcl90$2,488
Fesoterodine Fumarate ErFesoterodine Fumarate16$2,429

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$71$57,10638 claims
Novo NordiskOzempic$73$51,20729 claims
PfizerEliquis$64$47,77946 claims
GSKTrelegy Ellipta, Arexvy$30$16,99344 claims
AbbVieSynthroid$215$4,04042 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →